---
title: "Ipragliflozin - Diabetes Mellitus Type 2"
sidebar: mydoc_sidebar
permalink: db11698-mesh-d003924-1.html
toc: false 
---


Path ID: `DB11698_MESH_D003924_1`
{% include image.html url="images/db11698-mesh-d003924-1.png" file="db11698-mesh-d003924-1.png" alt="db11698-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C572941 | ipragliflozin | Drug |
| UniProt:P31639 | Sodium/glucose cotransporter 2 | Protein |
| REACT:R-HSA-189200 | Cellular hexose transport | Pathway |
| GO:0035623 | renal glucose absorption | BiologicalProcess |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ipragliflozin | DECREASES ACTIVITY OF | Sodium/Glucose Cotransporter 2 |
| Sodium/Glucose Cotransporter 2 | PARTICIPATES IN | Cellular Hexose Transport |
| Cellular Hexose Transport | REGULATES | Renal Glucose Absorption |
| Renal Glucose Absorption | POSITIVELY CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Ipragliflozin](https://en.wikipedia.org/wiki/Ipragliflozin)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/10453870#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/10453870#section=Pharmacology-and-Biochemistry)
